Molecule behind diverse
Andhra Pradesh ~ India ~ International ~ City ~ Entertainment ~ Business ~ Sports ~ Technology ~ Health ~ Features
Breast Cancer ~ Swine Flu ~ Lung Cancer ~ Heart attack ~ Pregnancy ~ All Health Topics
Home / Health News / 2008 / September 2008 / September 16, 2008
Molecule behind diverse human chronic inflammatory diseases identified
RSS / Print / Comments
Heart attack

European Medicines Agency approves TWYNSTA® (telmisartan plus amlodipine) a new single pill combination that delivers powerful and consistent blood pressure reductions throughout 24 hours

More strokes, fewer heart attacks with carotid stents: Study

Insulin resistance may be linked to stroke risk

More on Heart attack

Alzheimer's Disease

A faster way to look for drugs that regenerate nerve cells

Paralysed patient becomes world's first to get stem cell therapy

Experimental vaccine against Alzheimer's disease created

More on Alzheimer's Disease

Health News

New study confirms smoking, cancer link (reissue)
Taking up smoking results in epigenetic changes associated with the development of cancer, UK scientists have reported. ANI

Blame your mom for your muffin top or thunder thighs
A new study by an international team of researchers, including Cambridge and Oxford experts, has revealed that our propensity to be apple or pear-shaped is at least partly in our genes. ANI

Chemicals in mother's blood linked to child's obesity
A team of scientists has revealed that babies whose mothers had relatively high levels of the chemical DDE in their blood were more likely to both grow rapidly during their first 6 months and to have a high body ma*s index (BMI) by 14 months. ANI

Molecule behind diverse human chronic inflammatory diseases identified

Virginia Tech researchers have uncovered a common connection between the cellular innate immunity network and chronic inflammatory diseases like atherosclerosis, Type 2 Diabetes, and neurodegenerative diseases.

Washington, September 16 : Virginia Tech researchers have uncovered a common connection between the cellular innate immunity network and chronic inflammatory diseases like atherosclerosis, Type 2 Diabetes, and neurodegenerative diseases.

Research leader Liwu Li, an associate professor of Biological Sciences, says that the new finding offers a viable cellular and molecular target for the diagnosis and treatment of serious human inflammatory diseases.

"Researchers and physicians have long recognized that there is an association between these conditions. For example, obesity increases the risk of heart attack or stroke, Type 2 Diabetes or insulin resistance, and Alzheimer's Disease," said Li, who is the founding director of the Inflammation Center at Virginia Tech.

"Inflammation is the common mechanism. Inflammation is a double-edged sword. Proper inflammation is necessary to fend off infection and abnormal cell growth. On the other hand, excessive inflammation contributes to diverse chronic diseases, including atherosclerosis, diabetes, and lupus," he added.

The researcher, however, admitted that the research team were yet to understand the complex cellular and molecular networks controlling inflammation properly.

"The lack of understanding impedes our progress in treating serious chronic inflammatory diseases," he said.

For their research, the researchers studied transgenic mice that lacked a key cellular protein kinase named interlukin-1 receptor associated kinase 1 (IRAK-1), previously shown to be critical for processing diverse inflammatory signals.

Li and his colleagues found that IRAK-1 deficient mice were protected from developing atherosclerosis and insulin resistance.

The researchers also found that IRAK-1 prefers to phosphorylate transcription factors harbouring the Serine-Proline motif including STAT-3 and NFAT, which are involved in modulating the expression of distinct inflammatory mediators responsible for the excessive activation of specialized macrophages and T cells.

The cells eventually contribute to diverse inflammatory symptoms including cardiovascular diseases, diabetes, Alzheimer's diseases, and lupus.

"Chemical compounds targeting this molecule will have enormous therapeutic potential," Li said.

"There is still a long way to go for finding the actual cure for these diseases. That is why we are combining expertise from various disciplines, including experimental biology and computational simulation. The Inflammation Center integrates faculties with expertise in experimental molecular biology, cutting edge imaging of inflamed cells and tissues, computational simulation of cellular signaling networks, human and animal studies, and nano-technologies designing novel intervention," he said.

Virginia Tech Intellectual Properties Inc. (VTIP) filed a patent application for Li's discovery, and its use as a diagnostic tool and treatment strategy.

"This technology will still take some time before there is a product," said Li.


Suggested pages for your additional reading on Facebook

© 2000-2018 All Rights Reserved and are of their respective owners.
Disclaimer, Terms of Service & Privacy Policy | Contact Us